Skip to main content

Table 2 Programme losses (mortality and lost to follow-up (LTFU) in all adolescents and perinatally infected adolescents (9-19 years) compared with that of young adults (20-28 years)

From: Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa

  Mortality LTFU
Age group Rates (per 100 PYS) AHR* p-value Rates (per 100 PYS) AHR* p-value
All adolescents 1.2 (0.3-4.8) 0.56 (0.13-2.32) 0.42 7.2 (4.1-12.6) 0.74 (0.41-1.34) 0.33
Perinatally infected adolescents 0.8 (0.1-5.5) 0.39 (0.05-2.86) 0.35 3.9 (1.6-9.4) 0.39 (0.16-0.96) 0.04
Young adults (ref) 3.1 (2.4-3.9) 1.00 - 10.2 (9.0-11.7) 1.00 -
  1. PYS person-years; UHR unadjusted hazard ratio; AHR adjusted hazard ratio
  2. *adjusted for gender, baseline CD4, baseline viral load